Interesting question" As far as I am aware (I am clinical not research), the answer is yes. Many examples in oncology, and the whole idea of re-purposing drugs, in essence, utilises this pathway. Might well be something neuren are thinking of!
- Forums
- ASX - By Stock
- Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
Interesting question" As far as I am aware (I am clinical not...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.73 |
Change
0.430(2.23%) |
Mkt cap ! $2.491B |
Open | High | Low | Value | Volume |
$19.80 | $20.00 | $19.40 | $1.818M | 92.37K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 124 | $19.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.73 | 28 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 204 | 19.690 |
8 | 290 | 19.680 |
6 | 359 | 19.670 |
7 | 594 | 19.660 |
4 | 344 | 19.650 |
Price($) | Vol. | No. |
---|---|---|
19.720 | 188 | 3 |
19.730 | 508 | 5 |
19.740 | 381 | 6 |
19.750 | 956 | 9 |
19.760 | 523 | 4 |
Last trade - 13.28pm 11/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |